Neoefrapeptin N
| Internal ID | 16d181ac-0a8c-475e-83d0-6956af0d8b93 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (2S)-1-acetyl-N-[1-[2-[[1-[[1-[[(2S)-1-[[3-[[2-[[1-[[1-[(2S)-2-[[1-[[2-[[(2S)-1-[[1-[[(2S)-1-(2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidin-5-ium-1-yl)-4-methylpentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-2-methyl-1-oxopropan-2-yl]carbamoyl]piperidin-1-yl]-2-methyl-1-oxopropan-2-yl]carbamoyl]cyclopropyl]amino]-2-oxoethyl]amino]-3-oxopropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]carbamoyl]piperidin-1-yl]-2-methyl-1-oxopropan-2-yl]piperidine-2-carboxamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C80H134N18O16/c1-48(2)42-52(47-95-38-27-37-94-36-26-31-61(94)95)84-68(109)75(10,11)88-63(104)54(44-50(5)6)85-59(101)45-83-67(108)74(8,9)89-65(106)56-29-22-25-41-98(56)73(114)79(18,19)93-71(112)80(33-34-80)87-60(102)46-82-58(100)32-35-81-62(103)53(43-49(3)4)86-69(110)76(12,13)92-70(111)77(14,15)90-66(107)57-30-21-24-40-97(57)72(113)78(16,17)91-64(105)55-28-20-23-39-96(55)51(7)99/h48-50,52-57H,20-47H2,1-19H3,(H12-,81,82,83,84,85,86,87,88,89,90,91,92,93,100,101,102,103,104,105,106,107,108,109,110,111,112)/p+1/t52-,53-,54-,55-,56-,57?/m0/s1 |
| InChI Key | VIQJIFLMCJXDOX-VZYCVPBDSA-O |
| Popularity | 1 reference in papers |
| Molecular Formula | C80H135N18O16+ |
| Molecular Weight | 1605.00 g/mol |
| Exact Mass | 1604.03034529 g/mol |
| Topological Polar Surface Area (TPSA) | 445.00 Ų |
| XlogP | 1.40 |
| Atomic LogP (AlogP) | 0.41 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 13 |
| Rotatable Bonds | 37 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6643 | 66.43% |
| Caco-2 | - | 0.8569 | 85.69% |
| Blood Brain Barrier | - | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Lysosomes | 0.6089 | 60.89% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8304 | 83.04% |
| OATP1B3 inhibitior | + | 0.9352 | 93.52% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.7750 | 77.50% |
| BSEP inhibitior | + | 0.9530 | 95.30% |
| P-glycoprotein inhibitior | + | 0.7426 | 74.26% |
| P-glycoprotein substrate | + | 0.8437 | 84.37% |
| CYP3A4 substrate | + | 0.7464 | 74.64% |
| CYP2C9 substrate | - | 0.5996 | 59.96% |
| CYP2D6 substrate | - | 0.8376 | 83.76% |
| CYP3A4 inhibition | - | 0.8024 | 80.24% |
| CYP2C9 inhibition | - | 0.6950 | 69.50% |
| CYP2C19 inhibition | - | 0.6869 | 68.69% |
| CYP2D6 inhibition | - | 0.8464 | 84.64% |
| CYP1A2 inhibition | - | 0.8560 | 85.60% |
| CYP2C8 inhibition | + | 0.7312 | 73.12% |
| CYP inhibitory promiscuity | - | 0.9172 | 91.72% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.6251 | 62.51% |
| Eye corrosion | - | 0.9818 | 98.18% |
| Eye irritation | - | 0.8956 | 89.56% |
| Skin irritation | - | 0.7615 | 76.15% |
| Skin corrosion | - | 0.9046 | 90.46% |
| Ames mutagenesis | - | 0.5108 | 51.08% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6430 | 64.30% |
| Micronuclear | + | 0.8000 | 80.00% |
| Hepatotoxicity | + | 0.5227 | 52.27% |
| skin sensitisation | - | 0.8423 | 84.23% |
| Respiratory toxicity | + | 0.7222 | 72.22% |
| Reproductive toxicity | + | 0.8222 | 82.22% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.7897 | 78.97% |
| Acute Oral Toxicity (c) | III | 0.5989 | 59.89% |
| Estrogen receptor binding | + | 0.5278 | 52.78% |
| Androgen receptor binding | + | 0.7709 | 77.09% |
| Thyroid receptor binding | + | 0.7081 | 70.81% |
| Glucocorticoid receptor binding | + | 0.7780 | 77.80% |
| Aromatase binding | + | 0.7909 | 79.09% |
| PPAR gamma | + | 0.7654 | 76.54% |
| Honey bee toxicity | - | 0.7108 | 71.08% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | + | 0.6700 | 67.00% |
| Fish aquatic toxicity | + | 0.7432 | 74.32% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.86% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.94% | 96.09% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 98.20% | 98.10% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 97.57% | 97.21% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.34% | 98.33% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.18% | 98.24% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 96.10% | 97.25% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 96.02% | 95.00% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 95.97% | 95.17% |
| CHEMBL236 | P41143 | Delta opioid receptor | 95.89% | 99.35% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 95.44% | 96.95% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 95.13% | 89.33% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.78% | 97.14% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.62% | 91.19% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.42% | 91.11% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.23% | 90.71% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 94.09% | 100.00% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 93.92% | 94.45% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 92.83% | 96.67% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.64% | 93.56% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 92.18% | 96.28% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 91.98% | 94.45% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.61% | 93.10% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 91.32% | 95.34% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 91.15% | 94.00% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 90.96% | 94.05% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.38% | 90.08% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 90.27% | 90.00% |
| CHEMBL2782 | P35610 | Acyl coenzyme A:cholesterol acyltransferase 1 | 89.80% | 91.65% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 89.57% | 96.31% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 89.34% | 100.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 88.76% | 96.33% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 88.02% | 96.03% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 87.87% | 97.50% |
| CHEMBL5028 | O14672 | ADAM10 | 87.75% | 97.50% |
| CHEMBL3837 | P07711 | Cathepsin L | 87.50% | 96.61% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 87.24% | 83.10% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 87.00% | 93.04% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 86.52% | 96.25% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 86.44% | 90.24% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 85.82% | 93.33% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 85.78% | 90.93% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 85.72% | 92.50% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.25% | 96.90% |
| CHEMBL5646 | Q6L5J4 | FML2_HUMAN | 85.17% | 100.00% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 84.92% | 97.56% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.84% | 98.75% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 84.70% | 94.66% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 84.15% | 94.33% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 83.68% | 92.80% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 83.63% | 95.52% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 83.59% | 88.81% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.36% | 100.00% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 82.91% | 95.27% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 82.82% | 92.12% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 82.53% | 82.05% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 82.46% | 100.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 82.17% | 97.50% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 81.73% | 93.03% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.72% | 95.89% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 81.72% | 95.50% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 81.59% | 93.00% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 81.29% | 83.14% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 81.21% | 98.94% |
| CHEMBL238 | Q01959 | Dopamine transporter | 81.06% | 95.88% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 80.87% | 99.77% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 80.72% | 82.69% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 80.70% | 97.64% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 80.70% | 97.29% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 80.59% | 96.47% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 80.46% | 89.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 80.42% | 99.23% |
| CHEMBL3691 | Q13822 | Autotaxin | 80.04% | 96.39% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139584429 |
| LOTUS | LTS0171433 |
| wikiData | Q77368777 |